MD, MPH, MSc
Associate Professor, Medicine
Assistant Director, Community Outreach and Engagement
Assistant Director, Patient Engaged Research
UNC-Chapel Hill
Cancer Therapeutics Research Program
Meet Marjory Charlot
Area of Interest
Marjory Charlot, MD, MPH, MSc, is a thoracic medical oncologist with deep expertise in complex treatment decision-making and multidisciplinary care coordination. Her research program transcends disease-specific boundaries to address cancer care inequities across all tumor types, with particular focus on dismantling barriers that prevent equitable participation in clinical trials. Through innovative community engagement strategies and implementation science approaches, Dr. Charlot develops and tests interventions that transform how cancer care is delivered to medically underserved populations, ensuring that clinical trial participation reflects the diversity of patients who will ultimately benefit from breakthrough therapies. Her work combines rigorous scientific methodology with authentic community partnership to create sustainable solutions that advance health equity in oncology research and care delivery.
Awards and Honors
- University of North Carolina Simmons Scholar, 2020
- V Foundation Victory Ride to Cure Cancer Grant, 2019
- PCORI Eugene Washington Engagement Award, 2017
- Massachusetts Society of Clinical Oncology Innovation and Quality Grant, 2015
- Ruth L. Kirchstein National Research Service Award, 2013
News and Stories
Researchers awarded $11.2M grant to close endometrial cancer survival gap
The National Cancer Institute has awarded a Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to UNC Lineberger's Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD.
Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patients
Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.
